Elk Creek Partners, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.

Quarter-by-quarter ownership
Elk Creek Partners, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$17,907,000
-27.5%
246,251
+4.0%
3.08%
+8.2%
Q4 2019$24,702,000
-27.3%
236,862
-30.7%
2.84%
-2.8%
Q3 2019$33,998,000
+23.5%
341,554
+41.7%
2.92%
+42.1%
Q2 2019$27,523,000
+4.3%
241,110
+14.9%
2.06%
+8.1%
Q1 2019$26,377,000
+111.3%
209,823
+128.1%
1.90%
+83.6%
Q4 2018$12,482,000
-28.1%
91,984
+45.4%
1.04%
+10.6%
Q3 2018$17,365,000
-1.5%
63,263
-25.6%
0.94%
-3.4%
Q2 2018$17,627,000
+5.1%
85,083
-16.2%
0.97%
-1.0%
Q1 2018$16,773,000
-9.0%
101,556
-24.6%
0.98%
-9.6%
Q4 2017$18,438,000
+3.5%
134,650
+2.9%
1.08%
-3.4%
Q3 2017$17,823,000
+9.7%
130,905
-2.2%
1.12%
+6.7%
Q2 2017$16,241,000
+4.1%
133,782
-9.3%
1.05%
+10.2%
Q1 2017$15,605,000
+34.3%
147,437
+28.9%
0.96%
+21.8%
Q4 2016$11,618,000
-8.4%
114,339
-8.0%
0.78%
-6.2%
Q3 2016$12,686,000124,3010.84%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders